Literature DB >> 27070118

Sensitive analysis and pharmacokinetic study of the isomers paeoniflorin and albiflorin after oral administration of Total Glucosides Of White Paeony Capsule in rats.

Fei Fei1, Hailing Yang2, Ying Peng1, Pei Wang1, Shuyao Wang3, Yuqing Zhao1, Jingqiu Huang1, Xiaoyi Yu1, Siqi Feng1, Runbin Sun1, Na Yang1, Hongbo Wang4, Jiye Aa5, Guangji Wang6.   

Abstract

A sensitive and reliable method using liquid chromatography tandem mass spectrometry (LC-MS/MS) was established for the simultaneous assay of paeoniflorin and albiflorin in bio-samples of rats after liquid-liquid extraction with ethylacetate. For the first time, the developed method was validated and successfully applied to the pharmacokinetics study of paeoniflorin and albiflorin after oral administration of Total Glucosides Of White Paeony Capsule (TGP). Relative to the intravenous injection, the absolute bio-availabilities of paeoniflorin and albiflorin were 2.8 and 1.7%, while their excretion in feces was 43.06 and 40.87%, respectively. Both paeoniflorin and albiflorin showed dose-dependent exposure in plasma, with a half-life of approximately 1.8h. No significant differences were observed between a single equal dose of paeoniflorin or albiflorin and that of TGP for the pharmacokinetic parameters, including AUC, T1/2 and Cmax. Paeoniflorin and albiflorin were exposed at high levels in immune relevant organ/tissues, such as the spleen, thymus and bone, which could facilitate immuno-regulatory activities.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Albiflorin; LC–MS/MS; Paeoniflorin; Pharmacokinetics; Tissue distribution

Mesh:

Substances:

Year:  2016        PMID: 27070118     DOI: 10.1016/j.jchromb.2016.04.005

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  7 in total

1.  Paeoniflorin inhibits Th1 and Th17 cells in gut-associated lymphoid tissues to produce anti-arthritis activities.

Authors:  Fei Fei; Li-Xiang Aa; Qi Qi; Run-Bin Sun; Cai-Xia Yan; Ji-Ye Aa; Guang-Ji Wang
Journal:  Inflammopharmacology       Date:  2019-07-15       Impact factor: 4.473

2.  Novel treatment for refractory rheumatoid arthritis with total glucosides of paeony and nobiletin codelivered in a self-nanoemulsifying drug delivery system.

Authors:  Biao Qu; Xiao-Lin Wang; De-Chong Zheng; Chu-Tian Mai; Zhong-Qiu Liu; Hua Zhou; Ying Xie
Journal:  Acta Pharmacol Sin       Date:  2021-12-06       Impact factor: 7.169

Review 3.  Recent Insights Into the Protective Mechanisms of Paeoniflorin in Neurological, Cardiovascular, and Renal Diseases.

Authors:  Feng Jiao; Kevin Varghese; Shaoxun Wang; Yedan Liu; Hongwei Yu; George W Booz; Richard J Roman; Ruen Liu; Fan Fan
Journal:  J Cardiovasc Pharmacol       Date:  2021-06-01       Impact factor: 3.271

4.  Gut-brain axis metabolic pathway regulates antidepressant efficacy of albiflorin.

Authors:  Zhen-Xiong Zhao; Jie Fu; Shu-Rong Ma; Ran Peng; Jin-Bo Yu; Lin Cong; Li-Bin Pan; Zuo-Guang Zhang; Hui Tian; Chun-Tao Che; Yan Wang; Jian-Dong Jiang
Journal:  Theranostics       Date:  2018-11-13       Impact factor: 11.556

5.  Circadian Pharmacological Effects of Paeoniflorin on Mice With Urticaria-like Lesions.

Authors:  Li Peng; Lijuan Wen; Jie Zhang; Xiaotong Zhang; Qin Wei; Jing Guo; Jinhao Zeng
Journal:  Front Pharmacol       Date:  2022-02-09       Impact factor: 5.810

6.  Editorial: The interplay between food and intestinal microbiota: How they impact on the well-being status of the host.

Authors:  Marina Liso; Rachele De Giuseppe; Erica Pontonio
Journal:  Front Microbiol       Date:  2022-07-15       Impact factor: 6.064

7.  A pharmacokinetics-pharmacodynamics study of single-dose total glucosides of paeony capsule on reducing serum total bile acid in hepatic injury rats.

Authors:  Ninghua Jiang; Bohong Zheng; Yihan Feng; Lei Yin; Yuanrong Liu; Lujing Cao; Ning Zheng; Suxiang Wu; Baoyue Ding; Xuan Huang; Jeffrey Wang; Shuyu Zhan
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.